Pridinol

Pridinol
Clinical data
Trade names	Myopridin
AHFS/Drugs.com	International Drug Names
Routes of; administration	By mouth, parenteral
ATC code	M03BX03 (WHO) combinations M03BX53 (WHO);
Legal status
Legal status	UK: POM (Prescription only);
Identifiers
	IUPAC name 1,1-Diphenyl-3-(piperidin-1-yl)propan-1-ol;
CAS Number	511-45-5 ;
PubChem CID	4904;
DrugBank	DB00945 ;
ChemSpider	4735 ;
UNII	9E75Q6SUUB;
ChEMBL	ChEMBL404215 ;
CompTox Dashboard (EPA)	DTXSID0045090 ;
ECHA InfoCard	100.007.390
Chemical and physical data
Formula	C20H25NO
Molar mass	295.426 g·mol−1
	InChI InChI=1S/C20H25NO/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21/h1-2,4-7,10-13,22H,3,8-9,14-17H2 ; Key:RQXCLMGKHJWMOA-UHFFFAOYSA-N ;
	(what is this?) (verify)

Pridinol, sold under the brand name Myopridin, is a muscle relaxant that is used as an antiparkinsonian and anticholinergic drug.^[1] It has also been evaluated for the treatment of muscle related pain.^[2]

It was approved for medical use in the UK in May 2020.^[3] Pridinol bears structural similarity to another anti-muscarinic drug Diphenidol.

References

^ Budavari S, ed. (1989). The Merck index an encyclopedia of chemicals, drugs, and biologicals (11th ed., 2nd print. ed.). Rahway, NJ: Merck. p. 7747. ISBN 091191028X.
^ Überall MA, Essner U, Müller-Schwefe GH (July 2022). "Efficacy and safety/tolerability of pridinol: a meta-analysis of double-blind, randomized, placebo-controlled trials in adult patients with muscle pain". Current Medical Research and Opinion. 38 (7): 1141–1151. doi:10.1080/03007995.2022.2072089. PMID 35502575.
^ "Pridinol". SPS - Specialist Pharmacy Service. 10 August 2020. Retrieved 21 August 2020.

External links

"Pridinol". Drug Information Portal. U.S. National Library of Medicine. Archived from the original on August 15, 2022.

[1] Budavari S, ed. (1989). The Merck index an encyclopedia of chemicals, drugs, and biologicals (11th ed., 2nd print. ed.). Rahway, NJ: Merck. p. 7747. ISBN 091191028X.

[Überall_2022-2] Überall MA, Essner U, Müller-Schwefe GH (July 2022). "Efficacy and safety/tolerability of pridinol: a meta-analysis of double-blind, randomized, placebo-controlled trials in adult patients with muscle pain". Current Medical Research and Opinion. 38 (7): 1141–1151. doi:10.1080/03007995.2022.2072089. PMID 35502575.

[3] "Pridinol". SPS - Specialist Pharmacy Service. 10 August 2020. Retrieved 21 August 2020.

[1]

[2]

[3]